Rhythm Biosciences Limited (RHY.AX)
- Previous Close
0.0840 - Open
0.0900 - Bid 0.0840 x 946400
- Ask 0.0910 x 715200
- Day's Range
0.0840 - 0.0900 - 52 Week Range
0.0840 - 0.8300 - Volume
100,312 - Avg. Volume
186,650 - Market Cap (intraday)
20.662M - Beta (5Y Monthly) 2.69
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date Feb 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Rhythm Biosciences Limited, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
www.rhythmbio.comRecent News: RHY.AX
Performance Overview: RHY.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RHY.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RHY.AX
Valuation Measures
Market Cap
20.66M
Enterprise Value
19.44M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
16.62
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-2.56
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-91.64%
Return on Equity (ttm)
-171.97%
Revenue (ttm)
2.07M
Net Income Avi to Common (ttm)
-8.63M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
1.26M
Total Debt/Equity (mrq)
3.13%
Levered Free Cash Flow (ttm)
-5.17M
Company Insights: RHY.AX
RHY.AX does not have Company Insights